Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.33 | 0.08 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |